GCC Intravenous Solutions Market

GCC Intravenous Solutions Market Overview:

The GCC intravenous solutions market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028. Intravenous (IV) solutions are supplemental fluids that contain electrolytes, medications, water, and sugar. These solutions are prescribed to patients as per their medical condition, age, and body size, to restore fluid volume and treat the electrolyte balance. IV solutions offer nutrients to patients diagnosed with diabetes, cancer, immune deficiencies, heart failure, and other related diseases. In recent years, these solutions have gained momentum across the GCC region as they provide a rapid onset of drug effect as compared to other drug delivery systems.

One of the primary factors driving the market is the rising prevalence of malnutrition across the GCC countries. Additionally, intravenous solutions have a faster response time and efficacy, thereby creating a positive market outlook. Other than this, the rising geriatric population is positively influencing the market growth. Besides this, there is a significant rise in the prevalence of chronic illnesses, such as cancer and the natality rate. In line with this, the increasing incidences of gastrointestinal disorders, such as obesity, AIDS, disorders, and diabetes in the region, have propelled the market growth. Furthermore, governments of numerous GCC countries, such as Saudi Arabia, Qatar, and Oman, are undertaking initiatives to provide enhanced healthcare facilities to their citizens, which is consequently increasing the demand for IV solutions across the region.  Other than these factors, key players are extensively investing in research and development (R&D) activities to introduce new IV solution products for various diseases and the treatment of dehydration. Furthermore, the sudden outbreak of the coronavirus disease (COVID-19) has tremendously escalated the demand for intravenous injections. This is creating lucrative growth opportunities for the key players. IV nutrition is a vital aspect of any treatment to assist patients meet their nutritional needs and heal faster. Moreover, IV solutions are widely adopted to improve skin conditions and treat migraines and hangovers. Other growth-inducing factors include, the launch of ready-to-use, portable product variants, introduction of premixed solutions to avoid packaging waste, and rising investments in the healthcare sector. 

Beginning with a regional overview, the report explores the dynamics that have a strong influence on the GCC intravenous solutions market and can also impact its future growth. Taking 2022 as the base year, the report covers historical market scenario from 2017-2022 and provides forecasts till 2028. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry. On a regional basis, the report examines the GCC intravenous solutions market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. For each of these regions, the report studies the GCC intravenous solutions market in detail for latest trends, outlook and opportunities.

The report analyses the competitive structure of the GCC intravenous solutions market industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the GCC intravenous solutions market industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the GCC intravenous solutions market industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the GCC intravenous solutions market industry. Furthermore, the value chain analysis of the GCC intravenous solutions market industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution. 

GCC Intravenous Solutions Market Segment Insights:

The GCC intravenous solutions market has been analysed as followed:

By Type:

• Partial Parenteral Nutrition
• Total Parenteral Nutrition

By Nutrients:

• Carbohydrates
• Salts and Electrolytes
• Minerals
• Vitamins
• Amino Acids

By Country:

• Saudi Arabia
• UAE
• Qatar
• Oman
• Kuwait
• Bahrain

Country-wise, the market has been segmented into Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. Amongst these, Saudi Arabia represents the largest market, accounting for majority of the GCC region.

Competative Landscape: 

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Highlights of the GCC Intravenous Solutions Market Report:

• Historical and current scenario
• Trends and developments
• Impact of COVID-19
• Market forecast
• Price analysis and forecast
• Porter’s five forces analysis
• SWOT analysis
• Value chain analysis

Report Customisation:

The GCC intravenous solutions market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs